| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/27/2008 | EP1961767A2 Diagnosis and treatment of cancers and other conditions |
| 08/27/2008 | EP1961761A1 Novel peptide compound |
| 08/27/2008 | EP1961428A1 SC6 antibody for treatment of cancer |
| 08/27/2008 | EP1961425A2 Methods and compositions for the prevention and treatment of anemia |
| 08/27/2008 | EP1961065A2 Compositions and methods for diagnosing and treating cancer |
| 08/27/2008 | EP1960435A1 Domain-grafted antibodies |
| 08/27/2008 | EP1960434A2 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 |
| 08/27/2008 | EP1960433A2 Il-21 receptor antagonists |
| 08/27/2008 | EP1960432A2 Biological materials and uses thereof |
| 08/27/2008 | EP1960431A1 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
| 08/27/2008 | EP1960430A1 Antibody molecules having specificity for human il-6 |
| 08/27/2008 | EP1960429A2 Immunoglobulins directed against nogo |
| 08/27/2008 | EP1960428A1 Antibodies against amyloid beta 4 with glycosylated in the variable region |
| 08/27/2008 | EP1959997A2 Antagonists of hmgb1 and/or rage and methods of use thereof |
| 08/27/2008 | EP1959996A2 Monoclonal antibody |
| 08/27/2008 | EP1959993A2 Multivalent immunoglobulin-based bioactive assemblies |
| 08/27/2008 | EP1959991A2 Therapeutic vaccine |
| 08/27/2008 | EP1959728A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 08/27/2008 | EP1521774B1 Truncated tau proteins |
| 08/27/2008 | EP1481059B1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 08/27/2008 | EP1440156B1 Antigens and vectors for vaccination |
| 08/27/2008 | EP1384726B1 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 08/27/2008 | EP1382678B1 Guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same |
| 08/27/2008 | EP1355942B1 Glp-1 fusion proteins |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1322665B1 Hiv peptides from conserved regions in gag p17 and their applications, such as vaccines |
| 08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
| 08/27/2008 | EP1228086B1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/27/2008 | EP1115418B1 Diagnosis of cancers associated with viral infections using aglycoprotein 10B |
| 08/27/2008 | EP1028754B1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
| 08/27/2008 | EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1 |
| 08/27/2008 | CN101253264A 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ |
| 08/27/2008 | CN101253199A Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins |
| 08/27/2008 | CN101253198A Antibody produced using ostrich and method for production thereof |
| 08/27/2008 | CN101253197A Human fvii monoclonal antibodies binding the gla domain and use thereof |
| 08/27/2008 | CN101252951A Anti-IL-23 antibodies, compositions, methods and uses |
| 08/27/2008 | CN101252950A Immunoglobulins comprising predominantly a GLCNACMAN3GLCNAC2 sugar form |
| 08/27/2008 | CN101251539A Kit for early diagnosis of renal transplantation acute rejection |
| 08/27/2008 | CN101250229A Alanine aminopherase monoclonal antibody and use thereof |
| 08/27/2008 | CN101250228A Method for preparing bovine origin anti-avian influenza immune globulin |
| 08/27/2008 | CN101250227A Method for preparing against hog cholera immune globulin |
| 08/27/2008 | CN101250226A Method for preparing anti-PRRSV immune globulin |
| 08/27/2008 | CN101250215A Method for producing human rabies immune globulin |
| 08/27/2008 | CN101249265A Intravenous injection employ persons hepatitis B immune globulin and method of preparing the same |
| 08/27/2008 | CN101249264A Tuberculosis and medicament-resistant tubercular personalized yelk polyclone antibody and method of preparing the same and applications |
| 08/27/2008 | CN100413966C Delta-endotoxin genes and methods for their use |
| 08/27/2008 | CN100413888C Soluble polypeptides |
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/26/2008 | US7417136 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 08/26/2008 | US7417134 IL-1 receptor based cytokine traps and method of using |
| 08/26/2008 | US7417128 7C10 and 16C10 CD80-specific antibodies |
| 08/26/2008 | US7417127 Comprising heavy chain variable regions of amino acid sequence 1 or fragments, variants, fusion molecules thereof; cancer |
| 08/26/2008 | US7417126 Wound healing agents; anticancer agents; cardiovascular disorders |
| 08/26/2008 | US7417125 Chimeric humanized monoclonal antibody for treating tumors and inflammation |
| 08/26/2008 | US7417124 Polyclonal antibody specific for phosphorylated linker region in preferential transcription factor (SMAD) for use as tool in preventionand treatment of hepatic fibrosis and cell proliferative disorders; tissue targeted therapy; antitumor agents |
| 08/26/2008 | US7417123 PRO4399 Antibodies |
| 08/26/2008 | US7417115 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7416877 Type I transmembrane; cytokine receptor proteins having immunoregulatory activity; isolated DNA, recombinant expression vectors, transformed or transfected cells, monoclonal antibodies |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416853 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 08/26/2008 | US7416849 HBM variants that modulate bone mass and lipid levels |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416839 Immunoassay; for therapeutic treatment of Bovine spongiform encephalopathy (BSE) in cows, Scrapie disease in sheep and Creutzfeldt-Jacob syndrome in humans |
| 08/26/2008 | US7416733 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/26/2008 | US7416731 diagnosis and treatment of hair loss; producing the antibody by immunizing an animal with a Hairless antigen; conjugating the Hairless protein to a carrier |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416729 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 08/26/2008 | US7416728 Growth blocking agents |
| 08/26/2008 | US7416727 administering to the mammal a variant of a parent polypeptide comprising an Fc region; mediates antibody-dependent cell-mediated cytotoxicity (ADCC) in the presence of human effector cells more effectively than the parent polypeptide |
| 08/26/2008 | US7416726 Cytotoxicity; therapeutic antibody |
| 08/26/2008 | US7416725 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 08/26/2008 | CA2235225C Nima interacting proteins |
| 08/21/2008 | WO2008101184A2 Arl-1 specific antibodies |
| 08/21/2008 | WO2008100995A1 Humanized anti-cd100 antibodies |
| 08/21/2008 | WO2008100805A2 Anti-robo4 antibodies and uses therefor |
| 08/21/2008 | WO2008100624A2 Antibodies against erbb3 and uses thereof |
| 08/21/2008 | WO2008100578A2 Method of isolating antibodies by precipitation |
| 08/21/2008 | WO2008099969A1 Anti-fgf23 antibody and pharmaceutical composition comprising the same |
| 08/21/2008 | WO2008099968A1 Zinc oxide-binding antibody and use thereof |
| 08/21/2008 | WO2008099913A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 08/21/2008 | WO2008099188A1 Binding members for ige molecules |
| 08/21/2008 | WO2008099185A1 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 08/21/2008 | WO2008099178A2 Binding members for ige molecules |
| 08/21/2008 | WO2008099071A2 Monoclonal antibody directed against the human ldl receptor |
| 08/21/2008 | WO2008098917A2 Novel antibodies against igf-ir |
| 08/21/2008 | WO2008075349B1 Therapeutic methods using a thymus peptide |
| 08/21/2008 | WO2008073070A9 Antibodies to a spore specific glycosyl hydrolase |
| 08/21/2008 | WO2008068048A3 A novel passive vaccine for candida infections |
| 08/21/2008 | WO2008058127A9 Agonist trkb antibodies and uses thereof |
| 08/21/2008 | WO2008053275A3 Novel collection of hcdr3 regions and uses therefor |
| 08/21/2008 | WO2008051424A3 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 08/21/2008 | WO2008035217A3 Fusion proteins comprising two or more igg binding domains of streptococcal protein g. |
| 08/21/2008 | US20080201800 Antifungal Plant Proteins and Methods of Their Use |
| 08/21/2008 | US20080201789 Variants and exons of the glyt1 transporter |
| 08/21/2008 | US20080200664 Nucleotide sequences coding transcription factor (p63) for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/21/2008 | US20080200654 Recombinant human antibody that specifically attacks A33-expressing tumor cells with the use of antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity based on the immune system, and for which no human anti-humanized antibody is produced |
| 08/21/2008 | US20080200653 Compositions and methods for the diagnosis and treatment of tumor |
| 08/21/2008 | US20080200652 Immunoglobulin fusion for use as diagnostic sensor and drug screening tool |
| 08/21/2008 | US20080200414 HCaRG, A Novel Calcium-Regulated Gene |